Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATReceivables - Other
Ratios

Lipocine (LPCN) Accumulated Depreciation & Amortization (2016 - 2024)

Lipocine (LPCN) has disclosed Accumulated Depreciation & Amortization for 10 consecutive years, with $1.2 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Accumulated Depreciation & Amortization rose 3.48% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Dec 2024, up 3.48%, and an annual FY2024 reading of $1.2 million, up 3.48% over the prior year.
  • Accumulated Depreciation & Amortization was $1.2 million for Q4 2024 at Lipocine, up from $1.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.2 million in Q4 2024 and bottomed at $1.1 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 4 years is $1.2 million, with a median of $1.2 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization grew 0.83% in 2022, then grew 3.48% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $1.1 million in 2021, then increased by 0.83% to $1.2 million in 2022, then rose by 2.48% to $1.2 million in 2023, then grew by 3.48% to $1.2 million in 2024.
  • Business Quant data shows Accumulated Depreciation & Amortization for LPCN at $1.2 million in Q4 2024, $1.2 million in Q4 2023, and $1.2 million in Q4 2022.